David C. Baker

3.5k total citations
107 papers, 2.9k citations indexed

About

David C. Baker is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, David C. Baker has authored 107 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 46 papers in Organic Chemistry and 13 papers in Infectious Diseases. Recurrent topics in David C. Baker's work include Carbohydrate Chemistry and Synthesis (25 papers), Biochemical and Molecular Research (19 papers) and HIV/AIDS drug development and treatment (13 papers). David C. Baker is often cited by papers focused on Carbohydrate Chemistry and Synthesis (25 papers), Biochemical and Molecular Research (19 papers) and HIV/AIDS drug development and treatment (13 papers). David C. Baker collaborates with scholars based in United States, China and Germany. David C. Baker's co-authors include Chung K. Chu, Derek Horton, Lynn D. Hawkins, Sterling R. Putt, Wenli Gao, Yung‐Chi Cheng, Cong Jiang, Wing Lam, Donald K. Dougall and Vern L. Schramm and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

David C. Baker

105 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Baker United States 30 1.4k 1.2k 393 320 258 107 2.9k
Cheng‐Wei Tom Chang United States 31 1.5k 1.1× 1.2k 1.0× 198 0.5× 198 0.6× 116 0.4× 130 2.8k
Paul W. Groundwater United Kingdom 24 1.0k 0.7× 879 0.7× 246 0.6× 134 0.4× 90 0.3× 119 2.6k
Yukio Kitade Japan 32 2.5k 1.8× 938 0.8× 257 0.7× 378 1.2× 59 0.2× 245 4.1k
Diwan S. Rawat India 44 1.4k 1.0× 3.1k 2.5× 143 0.4× 542 1.7× 238 0.9× 169 4.9k
John F. Honek Canada 32 1.4k 1.1× 505 0.4× 179 0.5× 58 0.2× 210 0.8× 107 2.6k
Ross P. McGeary Australia 29 1.0k 0.8× 632 0.5× 127 0.3× 234 0.7× 147 0.6× 101 2.3k
Jatinder Singh India 31 1.2k 0.9× 850 0.7× 361 0.9× 106 0.3× 65 0.3× 108 3.0k
Maosheng Cheng China 36 2.7k 2.0× 2.1k 1.7× 251 0.6× 280 0.9× 236 0.9× 387 5.7k
Jennifer A. Littlechild United Kingdom 39 3.2k 2.3× 504 0.4× 583 1.5× 128 0.4× 493 1.9× 149 4.7k
Gerrit J. Poelarends Netherlands 41 2.5k 1.8× 1.3k 1.1× 149 0.4× 83 0.3× 265 1.0× 159 4.5k

Countries citing papers authored by David C. Baker

Since Specialization
Citations

This map shows the geographic impact of David C. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Baker more than expected).

Fields of papers citing papers by David C. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Baker. The network helps show where David C. Baker may publish in the future.

Co-authorship network of co-authors of David C. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Baker. A scholar is included among the top collaborators of David C. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Baker. David C. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ying, Sangwon Lee, Ya Ha, et al.. (2017). Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication. Scientific Reports. 7(1). 10037–10037. 17 indexed citations
2.
Wang, Ying, Wing Lam, Shaoru Chen, et al.. (2016). Tylophorine Analog DCB-3503 Inhibited Cyclin D1 Translation through Allosteric Regulation of Heat Shock Cognate Protein 70. Scientific Reports. 6(1). 32832–32832. 6 indexed citations
3.
O’Dell, William B., David C. Baker, & Sylvia E. McLain. (2012). Structural Evidence for Inter-Residue Hydrogen Bonding Observed for Cellobiose in Aqueous Solution. PLoS ONE. 7(10). e45311–e45311. 38 indexed citations
4.
Wang, Chao, Brian Sanders, & David C. Baker. (2011). Synthesis of a glycodendrimer incorporating multiple mannosides on a glucoside core. Canadian Journal of Chemistry. 89(8). 959–963. 12 indexed citations
5.
Yang, Qiang, et al.. (2007). Synthesis of a C-linked hyaluronic acid disaccharide mimetic. Carbohydrate Research. 342(12-13). 1668–1679. 6 indexed citations
6.
Gao, Wenli, Scott Bussom, Susan P. Grill, et al.. (2007). Structure–activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorganic & Medicinal Chemistry Letters. 17(15). 4338–4342. 70 indexed citations
7.
Baker, David C., et al.. (2004). Fluorinated cyclitols as useful biological probes of phosphatidylinositol metabolism. Carbohydrate Research. 339(9). 1585–1595. 21 indexed citations
8.
Tuinman, Albert A., et al.. (2003). Characterizing the electrospray-ionization mass spectral fragmentation pattern of enzymatically derived hyaluronic acid oligomers. Carbohydrate Research. 338(13). 1381–1387. 18 indexed citations
9.
Johnson, S. C., et al.. (1995). 1l-2,3:4,5-bis-O-(tetraisopropyldisiloxane-1,3-diyl)-chiro-inositol: a useful intermediate for the preparation of several novel cyclitols. Carbohydrate Research. 266(2). 301–307. 4 indexed citations
10.
Hawkins, Elma S., et al.. (1994). Synthesis of some 2-C-alkyl-2,3-dideoxy-α,β-l-glycero-tetrurono-1,4-lactones. Evaluation as antitumor agents. Carbohydrate Research. 253. 225–233. 6 indexed citations
11.
12.
Chu, Chung K. & David C. Baker. (1993). Nucleosides and Nucleotides as Antitumor and Antiviral Agents. 246 indexed citations
13.
Komada, Fusao, Teruo Okano, William I. Higuchi, et al.. (1991). Design of 9-β-D-Arabinofuranosyladenine (Ara-A) Transdermal Delivery System for Animal Studies: Regulation of Drug Concentration In Vivo. Journal of Pharmaceutical Sciences. 80(10). 935–941. 5 indexed citations
14.
Suhadolnik, Robert J., et al.. (1989). Stereospecific 2′-amination and 2′-chlorination of adenosine by Actinomadura in the biosynthesis of 2′-amino-2′-deoxyadenosine and 2′-chloro-2′-deoxycoformycin. Archives of Biochemistry and Biophysics. 270(1). 374–382. 8 indexed citations
15.
Suhadolnik, Robert J., et al.. (1989). Biosynthesis of 9-β-d-arabinofuranosyladenine: Hydrogen exchange at C-2′ and oxygen exchange at C-3′ of adenosine. Archives of Biochemistry and Biophysics. 270(1). 363–373. 4 indexed citations
16.
Hanvey, Jeffery C., et al.. (1988). 8-Ketodeoxycoformycin and 8-ketocoformycin as intermediates in the biosynthesis of 2'-deoxycoformycin and coformycin. Biochemistry. 27(15). 5790–5795. 8 indexed citations
17.
Paull, Kenneth D., Robert H. Shoemaker, Michael R. Boyd, et al.. (1988). The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water‐soluble formazan. Journal of Heterocyclic Chemistry. 25(3). 911–914. 111 indexed citations
19.
Narayanan, S., et al.. (1987). Relationship between breakage parameters and process variables in ball milling — An industrial case study. International Journal of Mineral Processing. 20(3-4). 241–251. 10 indexed citations
20.
Baker, David C., Theodore H. Haskell, Sterling R. Putt, & Bernard J. Sloan. (1979). Prodrugs of 9-(.beta.-D-arabinofuranosyl)adenine. 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives. Journal of Medicinal Chemistry. 22(3). 273–279. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026